Organization Overview
Alternative names
astragalus membranaceus (3 trials)
atorvastatin (lipitor) (1 trial)
clarithromycin (biaxin) (5 trials)
dapagliflozin (farxiga) (1 trial)
empagliflozin (jardiance) (1 trial)
esomeprazole (nexium) (1 trial)
celecoxib (celebrex) (2 trials)
cisplatin (platinol) (3 trials)
Adenocarcinoma (Phase 2)
Airway Obstruction (Phase 2)
Biliary Tract Diseases (Phase 2)
Bronchopulmonary Dysplasia (Phase 4)
Carcinoma (Phase 4)
Carcinoma, Ductal (Phase 3)
Carcinoma, Ductal, Breast (Phase 3)
Carcinoma, Hepatocellular (Phase 4)
Carcinoma in Situ (Phase 3)
Carcinoma, Intraductal, Noninfiltrating (Phase 3)
Carcinoma, Ovarian Epithelial (Phase 2)
Carcinoma, Squamous Cell (Phase 3)
Cerebral Infarction (Phase 4)
Cholangiocarcinoma (Phase 2)
Colonic Diseases (Phase 2)
Communicable Diseases (Phase 4)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 2 (Phase 4)
Fatigue (Phase 4)
Gastrointestinal Stromal Tumors (Phase 2)
Head and Neck Neoplasms (Phase 2)
Helicobacter Infections (Phase 4)
Hepatitis (Phase 2)
Hepatitis B (Phase 2)
Infections (Phase 4)
Ischemia (Phase 4)
Kidney Diseases (Phase 4)
Kidney Failure, Chronic (Phase 4)
Lung Diseases, Obstructive (Phase 1)
Lymphoma (Phase 2)
Lymphoma, B-Cell (Phase 2)
Lymphoma, Large B-Cell, Diffuse (Phase 2)
Lymphoma, Non-Hodgkin (Phase 2)
Meningitis (Phase 3)
Meningitis, Bacterial (Phase 3)
Mouth Neoplasms (Phase 3)
Nasopharyngeal Carcinoma (Phase 3)
Ovarian Neoplasms (Phase 2)
Pancreatic Neoplasms (Phase 2)
Peripheral Arterial Disease (Phase 4)
Peripheral Vascular Diseases (Phase 4)
Pulmonary Disease, Chronic Obstructive (Phase 1)
Rectal Neoplasms (Phase 2)
Recurrence (Phase 4)
Renal Insufficiency, Chronic (Phase 4)
Respiratory Distress Syndrome (Phase 4)
Respiratory Distress Syndrome, Newborn (Phase 4)
Sarcoma (Phase 2)
Squamous Cell Carcinoma of Head and Neck (Phase 2)
Stomach Neoplasms (Phase 2)
Stroke (Phase 4)